HOME › DRUGS › EMPAGLIFLOZIN;LINAGLIPTIN
ACTIVE SUBSTANCE / INN

EMPAGLIFLOZIN;LINAGLIPTIN

Brand name(s): Glyxambi
EMA LISTED
AUTHORISED
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Empagliflozin;Linagliptin
REGULATORS
EMA
SPONSORS / MAH
Boehringer Ingelheim International GmbH
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
GlyxambiBoehringer Ingelheim International GmbHAuthorised11/11/2016Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON EMPAGLIFLOZIN;LINAGLIPTIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →